Mostrar el registro sencillo del ítem
dc.contributor.author
Haymour, Layla
dc.contributor.author
Jean, Mickael
dc.contributor.author
Smulski, Cristian Roberto
dc.contributor.author
Legembre, Patrick
dc.date.available
2024-07-22T12:21:40Z
dc.date.issued
2023-11
dc.identifier.citation
Haymour, Layla; Jean, Mickael; Smulski, Cristian Roberto; Legembre, Patrick; CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways; Elsevier Science; Biochimica Et Biophysica Acta-reviews On Cancer; 1878; 6; 11-2023; 1-7
dc.identifier.issn
0304-419X
dc.identifier.uri
http://hdl.handle.net/11336/240476
dc.description.abstract
Although the interaction of CD95L (also known as FasL) with its so-called death receptor CD95 (Fas) induces anapoptotic signal responsible for the elimination of infected and cancer cells and maintenance of tissue homeostasis,this receptor can also implement non apoptotic signaling pathways. This latter signaling is involved inmetastatic dissemination in certain cancers and the severity of auto-immune disorders. The signaling complexityof this pair is increased by the fact that CD95 expression itself seems to contribute to oncogenesis via a CD95Lindependentmanner and, that both ligand and receptor might interact with other partners modulating theirpathophysiological functions. Finally, CD95L itself can trigger cell signaling in immune cells rendering complexthe interpretation of mouse models in which CD95 or CD95L are knocked out. Herein, we discuss these noncanonicalresponses and their biological functions.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier Science
dc.rights
info:eu-repo/semantics/restrictedAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
CD95
dc.subject
Ligand-independent signal
dc.subject
Nf-kB
dc.subject
Reverse signalling
dc.subject.classification
Otras Medicina Básica
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2024-07-19T11:53:25Z
dc.journal.volume
1878
dc.journal.number
6
dc.journal.pagination
1-7
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Haymour, Layla. Universite de Limoges; Francia. Inserm; Francia
dc.description.fil
Fil: Jean, Mickael. Université de Rennes I. Institut des Sciences Chimiques de Rennes; Francia
dc.description.fil
Fil: Smulski, Cristian Roberto. Comisión Nacional de Energía Atómica. Centro Atómico Bariloche; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Patagonia Norte; Argentina
dc.description.fil
Fil: Legembre, Patrick. Universite de Limoges; Francia
dc.journal.title
Biochimica Et Biophysica Acta-reviews On Cancer
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.bbcan.2023.189004
Archivos asociados